VBCG
CDMO

Valley Brook Capital Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Valley Brook Capital Group’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-58
Closed -$1K – 452
2021
Q1 		$1K Hold
58
– – ﹤0.01% 461
2020
Q4 		$0 Buy
+58
New +$530 ﹤0.01% 408

Other funds holding CDMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Valley Brook Capital Group's CDMO Position: Q2 2021 in Review

Valley Brook Capital Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2021, closing a stake of 58 shares — an estimated $1K sold.

Valley Brook Capital Group first reported a position in CDMO in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 172 funds tracked by Wall St. Rank hold CDMO as of Q2 2021.

  • Valley Brook Capital Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Valley Brook Capital Group sold 58 Avid Bioservices, Inc. Common Stock shares in Q2 2021, an estimated $1K.
  • Valley Brook Capital Group first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Valley Brook Capital Group's Avid Bioservices, Inc. Common Stock position peaked at $1K in Q1 2021.
  • 172 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2021.

Based on Valley Brook Capital Group's 13F filing for Q2 2021, filed 22 Jul 2021.